InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（10 笔）
内部人交易记录
其他已披露买入
0
已披露卖出
10
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Norry Elliot. Insider active across 1 company, notably Adaptimmune Therapeutics PLC. Aggregated, 10 filings have been recorded. Split: 0 buy · 10 sells. Total volume traded: €42k. History available since 4 January 2022. The latest transaction was disclosed on 17 January 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Norry Elliot
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
5,584 股@ US$0.58085.0% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-25-004608:0
4,268 股@ US$0.58793.9% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-25-003771:0
2,287 股@ US$0.792.6% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-24-004563:0
4,009 股@ US$0.83674.8% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-24-003743:0
2,159 股@ US$1.8585.9% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-23-004380:0
3,843 股@ US$1.74689.9% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-23-003535:0
876 股@ US$1.6942.2% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-23-001089:0
2,121 股@ US$3.191814.0% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-22-005054:0
3,770 股@ US$3.556727.9% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-22-004150:0
849 股@ US$4.06427.2% 占其流量American Depositary Shares representing Ordinary SharesSEC:0001104659-22-001669:0
10 条申报中的 10 条
About Norry Elliot
Norry Elliot is Chief Medical Officer at Adaptimmune Therapeutics PLC (XNAS). He has made 10 filings in total, and the 10 sampled filings, all sales, cover the period from 2022-01-05 to 2025-01-17, with sell volume of EUR 42486.
